Cochran John
SEC insider (Form 3/4/5 filer). CIK 0001406773. Director at Aquestive Therapeutics, Inc. (AQST) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 21, 2026. Located in WARREN, NJ.
Companies Cochran John has filed insider reports for
- Aquestive Therapeutics, Inc. (AQST): Director
- Crestline Lending Solutions, LLC (N/A): Officer, Chief Operating Officer
Cochran John
CIK: 0001406773
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 21, 2026AQST
Aquestive Therapeutics, Inc.
OtherDirect62.2K shares- - Jul 24, 2026No ticker
Crestline Lending Solutions, LLC
PurchaseDirect7.6K shares at avg. $19.63$150K - Jun 10, 2026AQST
Aquestive Therapeutics, Inc.
AwardDirectStock Option (Right to Purchase)
50.5K shares- - Jun 11, 2025AQST
Aquestive Therapeutics, Inc.
AwardDirectStock Option (Right to Purchase)
42K shares at avg. $3.41-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 21, 2026 |  AQST Aquestive Therapeutics, Inc. | Other | 62,229 | - | $0 | Direct |
| Jul 24, 2026 |  No ticker Crestline Lending Solutions, LLC | Purchase | 7,643 | $19.63 | $150,034 | Direct |
| Jun 10, 2026 | AQST Aquestive Therapeutics, Inc. | Award Stock Option (Right to Purchase) | 50,500 | - | - | Direct |
| Jun 11, 2025 | AQST Aquestive Therapeutics, Inc. | Award Stock Option (Right to Purchase) | 42,000 | $3.41 | - | Direct |
1-4 of 4 transactions